Tarsus Pharmaceuticals, Inc. reports

Company location: Irvine, CA
Fiscal year end: 31 December

Tarsus Pharmaceuticals, Inc. has filed 647 SEC EDGAR filings since 07 Aug 2020

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 526-550 of 647 matching filings.

Per page

25

Current page

22

4

FORM 4

Filing date: 03 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2021
Reporting date: 11 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Nov 2021
Reporting date: 08 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-39614

10-Q

Filing date: 10 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39614

8-K

Filing date: 09 Nov 2021
Reporting date: 09 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-260665

EFFECT filing

Filing date: 05 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Nov 2021
Reporting date: 02 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 03 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 03 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39614

8-K

Filing date: 01 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-3 File 333-260665

S-3

Filing date: 01 Nov 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Oct 2021
Reporting date: 12 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Oct 2021
Reporting date: 12 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Oct 2021
Reporting date: 08 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Oct 2021
Reporting date: 08 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Sep 2021
Reporting date: 01 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Sep 2021
Reporting date: 01 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Aug 2021
Reporting date: 11 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 12 Aug 2021
Reporting date: 11 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Aug 2021
Reporting date: 11 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Aug 2021
Reporting date: 10 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .